Suppr超能文献

医疗保险受益人门诊血压监测理赔报销的费率、金额及决定因素。

Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.

作者信息

Kent Shia T, Shimbo Daichi, Huang Lei, Diaz Keith M, Viera Anthony J, Kilgore Meredith, Oparil Suzanne, Muntner Paul

机构信息

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Center for Behavioral Cardiovascular Health, Department of Medicine, Columbia University Medical Center, New York, NY, USA.

出版信息

J Am Soc Hypertens. 2014 Dec;8(12):898-908. doi: 10.1016/j.jash.2014.09.020. Epub 2014 Oct 2.

Abstract

Ambulatory blood pressure monitoring (ABPM) can be used to identify white coat hypertension and guide hypertensive treatment. We determined the percentage of ABPM claims submitted between 2007 and 2010 that were reimbursed. Among 1970 Medicare beneficiaries with submitted claims, ABPM was reimbursed for 93.8% of claims that had an International Classification of Diseases, Ninth Revision, diagnosis code of 796.2 ("elevated blood pressure reading without diagnosis of hypertension") versus 28.5% of claims without this code. Among claims without an International Classification of Diseases, Ninth Revision, diagnosis code of 796.2 listed, those for the component (eg, recording, scanning analysis, physician review, reporting) versus full ABPM procedures and performed by institutional versus non-institutional providers were each more than two times as likely to be successfully reimbursed. Of the claims reimbursed, the median payment was $52.01 (25th-75th percentiles, $32.95-$64.98). In conclusion, educating providers on the ABPM claims reimbursement process and evaluation of Medicare reimbursement may increase the appropriate use of ABPM and improve patient care.

摘要

动态血压监测(ABPM)可用于识别白大衣高血压并指导高血压治疗。我们确定了2007年至2010年间提交的ABPM申请中获得报销的百分比。在1970名提交申请的医疗保险受益人中,国际疾病分类第九版诊断代码为796.2(“血压读数升高但未诊断为高血压”)的申请中有93.8%获得了ABPM报销,而没有此代码的申请中这一比例为28.5%。在未列出国际疾病分类第九版诊断代码796.2的申请中,由机构提供者与非机构提供者执行的部分(如记录、扫描分析、医生审核、报告)申请与完整ABPM程序申请相比,成功报销的可能性均高出两倍多。在获得报销的申请中,支付中位数为52.01美元(第25至75百分位数为32.95美元至64.98美元)。总之,对提供者进行ABPM申请报销流程教育以及评估医疗保险报销情况可能会增加ABPM的合理使用并改善患者护理。

相似文献

1
Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.
J Am Soc Hypertens. 2014 Dec;8(12):898-908. doi: 10.1016/j.jash.2014.09.020. Epub 2014 Oct 2.
2
The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010.
J Am Soc Hypertens. 2014 Dec;8(12):891-7. doi: 10.1016/j.jash.2014.09.015. Epub 2014 Sep 18.
4
Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace.
J Clin Hypertens (Greenwich). 2020 Jan;22(1):6-15. doi: 10.1111/jch.13772. Epub 2019 Dec 24.
6
Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.
Hypertension. 2012 Feb;59(2):384-9. doi: 10.1161/HYPERTENSIONAHA.111.185405. Epub 2012 Jan 3.
8
Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
Ann Pharmacother. 2011 Jul;45(7-8):910-5. doi: 10.1345/aph.1P771. Epub 2011 Jul 12.
9
Regional variation in the denial of reimbursement for bone mineral density testing among US Medicare beneficiaries.
J Clin Densitom. 2008 Oct-Dec;11(4):568-74. doi: 10.1016/j.jocd.2008.07.004. Epub 2008 Sep 12.

引用本文的文献

3
Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop Report.
Hypertension. 2023 Mar;80(3):503-522. doi: 10.1161/HYPERTENSIONAHA.122.19372. Epub 2022 Nov 30.
5
Masked Hypertension: Fragile in More Ways Than One.
Hypertension. 2020 Oct;76(4):1079-1080. doi: 10.1161/HYPERTENSIONAHA.120.15859. Epub 2020 Sep 9.
8
Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace.
J Clin Hypertens (Greenwich). 2020 Jan;22(1):6-15. doi: 10.1111/jch.13772. Epub 2019 Dec 24.
9
Patient perceptions of ambulatory blood pressure monitoring testing, tolerability, accessibility, and expense.
J Clin Hypertens (Greenwich). 2020 Jan;22(1):16-20. doi: 10.1111/jch.13760. Epub 2019 Dec 9.

本文引用的文献

1
Resistant hypertension: a review of diagnosis and management.
JAMA. 2014 Jun 4;311(21):2216-24. doi: 10.1001/jama.2014.5180.
2
Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH study.
PLoS One. 2014 Mar 24;9(3):e92522. doi: 10.1371/journal.pone.0092522. eCollection 2014.
3
Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions.
J Hum Hypertens. 2014 Sep;28(9):521-8. doi: 10.1038/jhh.2014.9. Epub 2014 Feb 27.
4
Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.
Hypertension. 2014 Apr;63(4):675-82. doi: 10.1161/HYPERTENSIONAHA.113.02741. Epub 2014 Jan 13.
6
European Society of Hypertension position paper on ambulatory blood pressure monitoring.
J Hypertens. 2013 Sep;31(9):1731-68. doi: 10.1097/HJH.0b013e328363e964.
7
Treated hypertension and the white coat phenomenon: Office readings are inadequate measures of efficacy.
J Am Soc Hypertens. 2013 May-Jun;7(3):236-43. doi: 10.1016/j.jash.2013.02.005. Epub 2013 Mar 21.
8
Cost-effectiveness of secondary screening modalities for hypertension.
Blood Press Monit. 2013 Feb;18(1):1-7. doi: 10.1097/MBP.0b013e32835d0fd3.
10
Three payer strategies to increase revenue.
J Med Pract Manage. 2012 Mar-Apr;27(5):268-71.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验